Primary Male Hypogonadism with Low Testosterone and Active Desire to Have Children
Clinical Scenario
This protocol applies to men with primary male hypogonadism who present with low serum testosterone and have an active desire to father children. The management of this specific combination requires a targeted approach that differs significantly from standard hormone replacement.
Key Fertility Consideration
Testosterone therapy must not be used when a patient has an active child wish, as it may suppress spermatogenesis. When hypogonadism coincides with fertility goals, the treatment strategy must be specifically tailored to preserve and support reproductive function.
Treatment Approach
In this setting, a gonadotropin-based regimen forms the basis of treatment. Depending on the individual patient's situation, a combination approach may be necessary. The specific agents, schedule, and sequence are detailed in the full protocol.
Treatment Goal
The primary clinical target is achieving normal physiological serum testosterone levels.
References
- If hypogonadism coincides with fertility issues, hCG treatment should be considered, especially in men with low gonadotropins (secondary hypogonadism).
- Do not use testosterone therapy in patients with male infertility or active child wish since it may suppress spermatogenensis.
- Normal physiological serum levels can be achieved with a standard dosage of 1,500-5,000 IU administered intramuscularly or subcutaneously twice weekly.
- In patients with secondary hypogonadism hCG treatment is combined with FSH treatment (usually 150 IU three times weekly intramuscular or subcutaneous) in adults as well as in adolescents.
- In cases of mild forms of secondary hypogonadism or in selected cases of primary hypogonadism induction of testosterone synthesis by hCG alone may lead to suppression of FSH (negative feedback of testosterone production) and has consequently also to be combined with FSH treatment if necessary.
View source ↗